Topical bleomycin vs placebo or no treatment
Safety of the intervention (adverse effects) · People with a diagnosis of oral leukoplakia
1 finding from 1 review
- Interventions for treating oral leukoplakia to prevent oral cancer 2016 · Cochrane All outcomesup to 3 monthsSoF 5, Safety of the intervention up to 3 months: 'All patients in the bleomycin group developed erythema with erosion by the end of the applications, whereas erythema developed in the placebo group. Discomfort was…1 studyGRADE not reported